LV10042B - The use of certain therapeutically active 4-substituted imidazoles for the manufacture of pharmaceutical preparations to be administered transdermally - Google Patents

The use of certain therapeutically active 4-substituted imidazoles for the manufacture of pharmaceutical preparations to be administered transdermally Download PDF

Info

Publication number
LV10042B
LV10042B LVP-92-19A LV920019A LV10042B LV 10042 B LV10042 B LV 10042B LV 920019 A LV920019 A LV 920019A LV 10042 B LV10042 B LV 10042B
Authority
LV
Latvia
Prior art keywords
drug
transdermal
preparation
formula
compounds
Prior art date
Application number
LVP-92-19A
Other languages
English (en)
Latvian (lv)
Other versions
LV10042A (lv
Inventor
Harry Jalonen
Risto Arvo Sakari Lammintausta
Original Assignee
Orion Yhtym Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtym Oy filed Critical Orion Yhtym Oy
Publication of LV10042A publication Critical patent/LV10042A/xx
Publication of LV10042B publication Critical patent/LV10042B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LVP-92-19A 1991-05-31 1992-05-28 The use of certain therapeutically active 4-substituted imidazoles for the manufacture of pharmaceutical preparations to be administered transdermally LV10042B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9111773A GB2256135B (en) 1991-05-31 1991-05-31 Transdermal administration of 4-substituted imidazoles

Publications (2)

Publication Number Publication Date
LV10042A LV10042A (lv) 1994-05-10
LV10042B true LV10042B (en) 1995-02-20

Family

ID=10695905

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-19A LV10042B (en) 1991-05-31 1992-05-28 The use of certain therapeutically active 4-substituted imidazoles for the manufacture of pharmaceutical preparations to be administered transdermally

Country Status (18)

Country Link
US (1) US5464628A (el)
EP (1) EP0586467B1 (el)
JP (1) JP3269822B2 (el)
AT (1) ATE199317T1 (el)
AU (1) AU1780892A (el)
CA (1) CA2110162C (el)
DE (1) DE69231709T2 (el)
DK (1) DK0586467T3 (el)
EE (1) EE02994B1 (el)
ES (1) ES2154636T3 (el)
FI (1) FI935350A0 (el)
GB (1) GB2256135B (el)
GR (1) GR3035499T3 (el)
IE (1) IE66188B1 (el)
LT (1) LT3005B (el)
LV (1) LV10042B (el)
NO (1) NO307365B1 (el)
WO (1) WO1992021334A1 (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997006788A1 (en) * 1995-08-14 1997-02-27 Janssen Pharmaceutica N.V. Transdermal administration of vorozole
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
DE19820151A1 (de) * 1998-05-06 1999-11-11 Hexal Ag Transdermales therapeutisches System zur Anwendung von Candesartan
TW200930291A (en) 2002-04-29 2009-07-16 Bayer Cropscience Ag Pesticidal heterocycles
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
AU2004325626B2 (en) * 2004-12-15 2010-12-09 Drossapharm Ag External patches containing etofenamate
CA2637308C (en) 2006-01-27 2014-02-25 F. Hoffmann-La Roche Ag Use of 4-imidazole derivatives for cns disorders
US20100179205A1 (en) * 2006-08-08 2010-07-15 Intervet International B.V. Composition for Enhanced Antiparasitic Activity
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
US20210323929A1 (en) * 2018-07-18 2021-10-21 Clexio Biosciences Ltd. Purified Detomidine, Process of Preparing and Methods of Use
US11185532B2 (en) 2019-05-01 2021-11-30 Clexio Biosciences Ltd. Methods of treating pruritus
CN112220767B (zh) * 2020-09-25 2022-10-25 安徽省公众检验研究院有限公司 一种盐酸阿替美唑缓释片的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
GB2069481B (en) * 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
GB2167408B (en) 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
US4672344A (en) 1985-04-19 1987-06-09 Siemens Aktiengesellschaft Polarized electromagnetic relay
FI864570A0 (fi) 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
US5304569A (en) * 1989-11-13 1994-04-19 Orion-Yhtyma Oy Compositions and their use in lowering intraocular pressure

Also Published As

Publication number Publication date
AU1780892A (en) 1993-01-08
DE69231709T2 (de) 2001-10-04
ES2154636T3 (es) 2001-04-16
IE66188B1 (en) 1995-12-13
DK0586467T3 (da) 2001-03-26
IE921938A1 (en) 1992-12-02
NO934261L (no) 1993-11-25
EE02994B1 (et) 1997-06-16
NO934261D0 (no) 1993-11-25
CA2110162C (en) 2002-11-12
LTIP111A (lt) 1994-03-25
LV10042A (lv) 1994-05-10
ATE199317T1 (de) 2001-03-15
JP3269822B2 (ja) 2002-04-02
FI935350A (fi) 1993-11-30
DE69231709D1 (de) 2001-04-05
NO307365B1 (no) 2000-03-27
EP0586467A1 (en) 1994-03-16
US5464628A (en) 1995-11-07
GR3035499T3 (en) 2001-06-29
EP0586467B1 (en) 2001-02-28
GB9111773D0 (en) 1991-07-24
CA2110162A1 (en) 1992-12-10
GB2256135A (en) 1992-12-02
LT3005B (lt) 1994-08-25
FI935350A0 (fi) 1993-11-30
WO1992021334A1 (en) 1992-12-10
GB2256135B (en) 1995-01-18
JPH06507618A (ja) 1994-09-01

Similar Documents

Publication Publication Date Title
CA2110161C (en) Medetomidine preparations for transdermal administration
US4732892A (en) L-α-amino acids as transdermal penetration enhancers
US5820875A (en) Device for administering drug transdermally with a controlled temporal change in skin flux
US5308625A (en) Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters
US5591767A (en) Liquid reservoir transdermal patch for the administration of ketorolac
EP0676962B1 (en) Enhanced pharmaceutical compositions for skin penetration for piroxicam
EP0586467B1 (en) Pharmaceutical compositions containing 4-substituted imidazoles to be administered transdermally
IE912108A1 (en) Transdermal administration of buprenorphine
US5358715A (en) Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters
ZA200506056B (en) Formulation and methods for the treatment of thrombocythemia
KR100624500B1 (ko) 레리세트론 전달용 경피치료시스템
KR20030021418A (ko) 펜타닐 경피 투여 제제
JP2717859B2 (ja) 経皮吸収製剤